People throughout Minnesota will now have better access to leading-edge clinical research trials, thanks to a partnership between the University of Minnesota and the state’s major health systems.

The Minnesota Cancer Clinical Trials Network (MNCCTN), with six of 18 locations now open across the state, aims to improve cancer prevention, treatment, and survivorship for all Minnesotans. Trials originate from the Masonic Cancer Center, University of Minnesota, and Mayo Clinic Cancer Center—Minnesota’s Comprehensive Cancer Centers as designated by the National Cancer Institute— as well as from the Hormel Institute in Austin, Minn.

The MNCCTN is funded by the state via Minnesota’s Discovery, Research and InnoVation Economy (MnDRIVE) initiative, with additional support from Minnesota Masonic Charities for the trials within it.

For information on new clinical trial locations, visit mncancertrials.umn.edu.